Moderna Reveals COVID-19 Vaccine Nearly 95% Effective In Latest “Breakthrough” Results

US biotech firm Mod­er­na on Mon­day announced its exper­i­men­tal vac­cine against Covid-19 was almost 95 per­cent effec­tive, mark­ing a sec­ond major break­through in the quest to end the pandemic.

Mod­er­na released ear­ly results from a clin­i­cal tri­al with more than 30,000 par­tic­i­pants, after Amer­i­can phar­ma­ceu­ti­cal com­pa­ny Pfiz­er and its Ger­man part­ner BioN­Tech last week said their vac­cine was 90 per­cent effective.

Both fron­trun­ners are based on new tech­nol­o­gy that uses syn­thet­ic ver­sions of mol­e­cules called “mes­sen­ger RNA” to hack into human cells, and effec­tive­ly turn them into vac­cine-mak­ing factories.

“This pos­i­tive inter­im analy­sis from our Phase 3 study has giv­en us the first clin­i­cal val­i­da­tion that our vac­cine can pre­vent COVID-19 dis­ease, includ­ing severe dis­ease,” said Mod­er­na CEO Stephane Bancel.

NEVER MISS OUT! Join our popular newsletter


Big Tech is at war with you! They don't want you to see the truth.



. . .
Send this to a friend